ArticleJACC. Advances2026
Associations of Central Adiposity With Subclinical Coronary Calcification and Disease Progression: Meta-Analysis of 68,629 Participants.
Article in JACC. Advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Rethinking cardiometabolic therapy thresholds in individuals with obesity.International journal of obesity (2005) · 2026Review
- Central Adiposity and Subclinical Coronary Atherosclerosis in Population-Based Studies: What Are We Missing Beyond Waist Circumference?JACC. Advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCoronary artery calcium (CAC) is a robust marker of subclinical atherosclerosis and cardiovascular risk. Body mass index (BMI) may inadequately reflect central adiposity, which may be more strongly associated with CAC burden and progression.
objectivesThe objective of the study was to compare associations of BMI, waist circumference (WC), and waist-to-hip ratio (WHR) with CAC presence and progression in individuals without established cardiovascular disease.
methodsA systematic search of PubMed, MEDLINE, Embase, CINAHL, Scopus, and gray literature (January 2000-March 2025) identified studies reporting anthropometric measures by CAC status (CAC = 0 vs >0) or progression. Two reviewers applied Preferred Reporting Items for Systematic reviews and Meta-Analyses-based criteria. Standardized mean differences (SMDs) were pooled using random-effects models. Heterogeneity was assessed with I-squared statistic (I
resultsForty-nine studies were included (33 CAC presence; 16 progression) across 10 countries. For CAC presence (n = 43,490), WHR (SMD: 0.46; 95% CI: 0.35-0.56; I
conclusionsCentral adiposity measures (WHR and WC) show stronger associations with CAC presence and progression than BMI, supporting their use as markers of cardiovascular risk while highlighting limitations of BMI alone. (Anthropometrics and subclinical coronary artery calcification: a systematic review and meta-analysis; CRD420251083057).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.